Imatinib in Systemic Sclerosis

Clinical Trial ID NCT00506831

PubWeight™ 2.96‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00506831

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A 2003 2.87
2 Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 2009 1.22
3 Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 2011 0.93
4 Pharmacotherapy of systemic sclerosis. Expert Opin Pharmacother 2010 0.86
Next 100